Ergin Eroğlu, Burçay Tellioğlu, Yasin Gökçınar, Serdar Özer
Isolated superior orbital roof blow-in fractures are rare and may result in functional or aesthetic impairment requiring surgical intervention. This case report demonstrates the successful endoscopic repair of such a fracture, emphasizing the advantages of endoscopic techniques in achieving adequate visualization when direct access to the fracture site is limited.
{"title":"Endoscopic Repair of a Superior Orbital Roof Blow-In Fracture: A Rare Case Report.","authors":"Ergin Eroğlu, Burçay Tellioğlu, Yasin Gökçınar, Serdar Özer","doi":"10.1002/lary.70387","DOIUrl":"https://doi.org/10.1002/lary.70387","url":null,"abstract":"<p><p>Isolated superior orbital roof blow-in fractures are rare and may result in functional or aesthetic impairment requiring surgical intervention. This case report demonstrates the successful endoscopic repair of such a fracture, emphasizing the advantages of endoscopic techniques in achieving adequate visualization when direct access to the fracture site is limited.</p>","PeriodicalId":49921,"journal":{"name":"Laryngoscope","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146013178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abdul-Latif Hamdan, Lana Ghzayel, Lucien Khalil, Valerie Sarkis, Ghena Lababidi, Jad Hosri, Ibana Carapiperis, Patrick Abou Raji Feghali
Objective: To describe the prevalence and morphology of vocal fold contralateral reactive lesions in patients with vocal fold polyps or cysts, and to report disease regression following office-based laryngeal surgery (OBLS).
Methods: Medical records and video recordings of patients with vocal fold polyps or cysts who underwent OBLS between November 2023 and September 2025 were reviewed. Demographic data included age, gender, history of smoking, history of reflux disease, type of vocal fold pathology, and type of office-based laryngeal procedure. Prevalence, morphology, and disease regression of CRLs were assessed by two otolaryngologists who independently reviewed the video recordings of patients included in this study.
Results: Twenty-six males and 19 females were included in the study. The mean age was 48.9 ± 14.9 years. The prevalence of CRLs was 60%. Most of these lesions were fibrous. Eighteen lesions were treated with ILSI, and 8 lesions were treated with the blue laser and steroid injection. Five patients were lost to follow-up. Analysis of 21 CRLs showed complete disease regression in 52.4% of cases, and partial disease regression in 47.6% of cases. There was no statistically significant difference in disease regression between the two treatment subgroups (p = 0.284). There was a statistically significant difference in total disease regression of the primary lesion between those who had partial vs. complete disease regression of their CRL (p < 0.001).
Conclusion: CRLs are common in patients with vocal fold polyps and cysts. All lesions regressed partially or completely following OBLS using the blue laser and/or steroid injection.
{"title":"Disease Regression of Contralateral Reactive Lesions Following Office-Based Laryngeal Surgery.","authors":"Abdul-Latif Hamdan, Lana Ghzayel, Lucien Khalil, Valerie Sarkis, Ghena Lababidi, Jad Hosri, Ibana Carapiperis, Patrick Abou Raji Feghali","doi":"10.1002/lary.70389","DOIUrl":"https://doi.org/10.1002/lary.70389","url":null,"abstract":"<p><strong>Objective: </strong>To describe the prevalence and morphology of vocal fold contralateral reactive lesions in patients with vocal fold polyps or cysts, and to report disease regression following office-based laryngeal surgery (OBLS).</p><p><strong>Methods: </strong>Medical records and video recordings of patients with vocal fold polyps or cysts who underwent OBLS between November 2023 and September 2025 were reviewed. Demographic data included age, gender, history of smoking, history of reflux disease, type of vocal fold pathology, and type of office-based laryngeal procedure. Prevalence, morphology, and disease regression of CRLs were assessed by two otolaryngologists who independently reviewed the video recordings of patients included in this study.</p><p><strong>Results: </strong>Twenty-six males and 19 females were included in the study. The mean age was 48.9 ± 14.9 years. The prevalence of CRLs was 60%. Most of these lesions were fibrous. Eighteen lesions were treated with ILSI, and 8 lesions were treated with the blue laser and steroid injection. Five patients were lost to follow-up. Analysis of 21 CRLs showed complete disease regression in 52.4% of cases, and partial disease regression in 47.6% of cases. There was no statistically significant difference in disease regression between the two treatment subgroups (p = 0.284). There was a statistically significant difference in total disease regression of the primary lesion between those who had partial vs. complete disease regression of their CRL (p < 0.001).</p><p><strong>Conclusion: </strong>CRLs are common in patients with vocal fold polyps and cysts. All lesions regressed partially or completely following OBLS using the blue laser and/or steroid injection.</p><p><strong>Level of evidence: 3: </strong></p>","PeriodicalId":49921,"journal":{"name":"Laryngoscope","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146013084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"In Reference to Tracheostomy Dependence in Hypopharyngeal Cancer: Comparative Prognostic Impact of CRT Versus Surgery.","authors":"Lala Sha, Xiaohong Xie","doi":"10.1002/lary.70349","DOIUrl":"https://doi.org/10.1002/lary.70349","url":null,"abstract":"","PeriodicalId":49921,"journal":{"name":"Laryngoscope","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146004428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hannah N W Weinstein, Michael W Denham, Lauren H Tucker, Justin S Golub, Hayley L Born
Objectives: Previous studies have examined the relationship between dysphonia and mental health, but often in small samples and not across age groups. In this large national epidemiological study, we examine if dysphonia is related to anxiety and depression generally and across cohorts of different ages.
Methods: This is a cross-sectional analysis of adults ≥ 18 years old in the All of Us dataset. The exposure was dysphonia (ICD-10 code R49.0), and the outcomes were anxiety (ICD-10 F41) and depression (ICD-10 F32-33). We performed multivariable logistic regression analyses, controlling for age, gender, race, ethnicity, insurance, education, smoking history, alcohol use, and medical comorbidities. A sub-analysis compared depression and anxiety odds across two and five age groups.
Results: Of 283,137 adults in our sample, the mean age was 56 years (standard deviation 16 years). Sixty-one percent identified as female. Controlling for covariates, those with dysphonia had 1.34 times (95% CI 1.27-1.41) the odds of depression and 1.44 times (1.37-1.52) the odds of anxiety compared to their non-dysphonia counterparts. After stratifying by age, the odds of depression and anxiety were 2.36 times (1.67-3.35) and 1.62 (1.14-2.30) respectively for participants ≥ 18-30 years old, 1.61 (1.37-1.89) and 1.75 (1.49-2.07) for > 30-45 year olds, 1.38 (1.23-1.55) and 1.46 (1.33-1.67) for > 45-60 year olds, 1.33 (1.23-1.44) and 1.46 (1.35-1.58) for > 60-75 year olds, and 1.22 (1.09-1.35) and 1.36 (1.22-1.51) for > 75 year olds.
Conclusions: Those with dysphonia had higher odds of depression and anxiety. Following stratification by age, the odds for each were highest for the youngest age group.
Level of evidence: 3:
目的:以前的研究已经检查了语音障碍和心理健康之间的关系,但通常是小样本的,而不是跨年龄组的。在这项大型的全国流行病学研究中,我们研究了语音障碍是否与焦虑和抑郁有关,并在不同年龄的队列中进行了研究。方法:对All of Us数据集中年龄≥18岁的成年人进行横断面分析。暴露为语音障碍(ICD-10代码R49.0),结果为焦虑(ICD-10 F41)和抑郁(ICD-10 F32-33)。我们进行了多变量logistic回归分析,控制了年龄、性别、种族、民族、保险、教育、吸烟史、酒精使用和医疗合并症。一项亚分析比较了两个和五个年龄组的抑郁和焦虑几率。结果:在我们的样本中,283,137名成年人的平均年龄为56岁(标准差为16岁)。61%被认定为女性。控制协变量后,与非语音障碍患者相比,语音障碍患者抑郁的几率为1.34倍(95% CI 1.27-1.41),焦虑的几率为1.44倍(1.37-1.52)。按年龄分层后,年龄≥18-30岁的参与者抑郁和焦虑的几率分别为2.36倍(1.67-3.35)和1.62倍(1.14-2.30),30-45岁的参与者抑郁和焦虑的几率分别为1.61倍(1.37-1.89)和1.75倍(1.49-2.07),45-60岁的参与者抑郁和焦虑的几率分别为1.38倍(1.23-1.55)和1.46倍(1.33-1.67),60-75岁的参与者抑郁和焦虑的几率分别为1.33倍(1.23-1.44)和1.46倍(1.35-1.58),75岁的参与者抑郁和焦虑的几率分别为1.22(1.09-1.35)和1.36倍(1.22-1.51)。结论:语音障碍患者抑郁和焦虑的几率更高。在按年龄分层之后,年龄最小的年龄组的患病几率最高。证据等级:3;
{"title":"Dysphonia Is Associated With Anxiety and Depression in the All of Us Research Program.","authors":"Hannah N W Weinstein, Michael W Denham, Lauren H Tucker, Justin S Golub, Hayley L Born","doi":"10.1002/lary.70372","DOIUrl":"https://doi.org/10.1002/lary.70372","url":null,"abstract":"<p><strong>Objectives: </strong>Previous studies have examined the relationship between dysphonia and mental health, but often in small samples and not across age groups. In this large national epidemiological study, we examine if dysphonia is related to anxiety and depression generally and across cohorts of different ages.</p><p><strong>Methods: </strong>This is a cross-sectional analysis of adults ≥ 18 years old in the All of Us dataset. The exposure was dysphonia (ICD-10 code R49.0), and the outcomes were anxiety (ICD-10 F41) and depression (ICD-10 F32-33). We performed multivariable logistic regression analyses, controlling for age, gender, race, ethnicity, insurance, education, smoking history, alcohol use, and medical comorbidities. A sub-analysis compared depression and anxiety odds across two and five age groups.</p><p><strong>Results: </strong>Of 283,137 adults in our sample, the mean age was 56 years (standard deviation 16 years). Sixty-one percent identified as female. Controlling for covariates, those with dysphonia had 1.34 times (95% CI 1.27-1.41) the odds of depression and 1.44 times (1.37-1.52) the odds of anxiety compared to their non-dysphonia counterparts. After stratifying by age, the odds of depression and anxiety were 2.36 times (1.67-3.35) and 1.62 (1.14-2.30) respectively for participants ≥ 18-30 years old, 1.61 (1.37-1.89) and 1.75 (1.49-2.07) for > 30-45 year olds, 1.38 (1.23-1.55) and 1.46 (1.33-1.67) for > 45-60 year olds, 1.33 (1.23-1.44) and 1.46 (1.35-1.58) for > 60-75 year olds, and 1.22 (1.09-1.35) and 1.36 (1.22-1.51) for > 75 year olds.</p><p><strong>Conclusions: </strong>Those with dysphonia had higher odds of depression and anxiety. Following stratification by age, the odds for each were highest for the youngest age group.</p><p><strong>Level of evidence: 3: </strong></p>","PeriodicalId":49921,"journal":{"name":"Laryngoscope","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146004490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"In Response to Tracheostomy Dependence in Hypopharyngeal Cancer: Comparative Prognostic Impact of CRT Versus Surgery.","authors":"Chien-Yi Yang, Shao-Cheng Liu","doi":"10.1002/lary.70347","DOIUrl":"https://doi.org/10.1002/lary.70347","url":null,"abstract":"","PeriodicalId":49921,"journal":{"name":"Laryngoscope","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146004441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Courtney J Hunter, John L Dornhoffer, Robert A Saadi
{"title":"What Is the Optimal Timing for Cochlear Implantation in a Post-Meningitic Infant With Sensorineural Hearing Loss?","authors":"Courtney J Hunter, John L Dornhoffer, Robert A Saadi","doi":"10.1002/lary.70358","DOIUrl":"https://doi.org/10.1002/lary.70358","url":null,"abstract":"","PeriodicalId":49921,"journal":{"name":"Laryngoscope","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146004438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Benjamin Aunins, Samuel Oyer, Vusala Snyder, Stephen Park
{"title":"Is There a Topical Nasal Steroid Spray That Works the Best for Nasal Congestion?","authors":"Benjamin Aunins, Samuel Oyer, Vusala Snyder, Stephen Park","doi":"10.1002/lary.70375","DOIUrl":"https://doi.org/10.1002/lary.70375","url":null,"abstract":"","PeriodicalId":49921,"journal":{"name":"Laryngoscope","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145999389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sohil Singh, Sagar Singh Matharu, Ankit Choudhury, Ryan Puccia
Objective: To evaluate whether preoperative sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with postoperative complications in adults with type 2 diabetes mellitus (T2DM) undergoing open surgical tracheostomy (OST).
Methods: We performed a retrospective cohort study using a multi-institutional electronic health record network. Adults with T2DM who underwent OST between 2013 and 2024 were identified using CPT and ICD-10-PCS codes. Exposure was defined as an SGLT2i prescription within 180 days before surgery. One-to-one propensity score matching on demographics, comorbidities, preoperative ventilator dependence, medications, and laboratory values generated balanced SGLT2i and non-SGLT2i cohorts. Ninety- and 180-day postoperative complications were compared using odds ratios (ORs) with 95% confidence intervals, with Benjamini-Hochberg false discovery rate (FDR) correction.
Results: Of 36,840 eligible adults (1329 SGLT2i; 35,511 non-SGLT2i), 1327 patients remained in each cohort after matching. At 90 days, SGLT2i use was associated with higher odds of heart failure exacerbation (OR 1.70, 95% CI 1.36-2.14), which remained significant after FDR adjustment. At 180 days, SGLT2i use was associated with increased odds of hypoglycemia (OR 2.01, 95% CI 1.30-3.13) and heart failure exacerbation (OR 1.61, 95% CI 1.30-1.99), both significant after FDR correction. Signals for surgical site infection, tracheostomy stoma malfunction, and dizziness/vertigo did not remain significant after adjustment.
Conclusion: In adults with T2DM undergoing OST, preoperative SGLT2i use was associated with increased postoperative hypoglycemia and heart failure exacerbation. These findings support careful perioperative management of SGLT2is in high-risk airway surgery and justify prospective studies to define optimal discontinuation strategies.
Level of evidence: 3
目的:评估接受开放性气管切开术(OST)的成人2型糖尿病(T2DM)患者术前使用钠-葡萄糖共转运蛋白2抑制剂(SGLT2i)是否与术后并发症相关。方法:我们使用多机构电子健康记录网络进行了一项回顾性队列研究。使用CPT和ICD-10-PCS代码确定2013年至2024年间接受OST的T2DM成人。暴露被定义为术前180天内服用SGLT2i处方。在人口统计学、合并症、术前呼吸机依赖、药物和实验室值方面进行一对一倾向评分匹配,生成平衡的SGLT2i和非SGLT2i队列。采用95%置信区间的优势比(ORs)比较90天和180天的术后并发症,并校正benjamin - hochberg错误发现率(FDR)。结果:在36840名符合条件的成年人中(1329名SGLT2i患者;35511名非SGLT2i患者),每个队列中匹配后仍有1327名患者。在第90天,SGLT2i的使用与心力衰竭加重的较高几率相关(OR 1.70, 95% CI 1.36-2.14),在FDR调整后仍然显著。在180天,SGLT2i的使用与低血糖(OR 2.01, 95% CI 1.30-3.13)和心力衰竭加重(OR 1.61, 95% CI 1.30-1.99)的几率增加相关,这两项在FDR校正后均具有显著性。调整后,手术部位感染、气管造口术、造口功能障碍和头晕/眩晕的信号不再明显。结论:在接受OST的成年T2DM患者中,术前使用SGLT2i与术后低血糖增加和心力衰竭加重有关。这些发现支持高危气道手术中sglt2i患者围手术期的谨慎管理,并为前瞻性研究确定最佳停药策略提供了依据。证据等级:3;
{"title":"Preoperative SGLT2 Inhibitors and Postoperative Complications After Tracheostomy in Type 2 Diabetes.","authors":"Sohil Singh, Sagar Singh Matharu, Ankit Choudhury, Ryan Puccia","doi":"10.1002/lary.70374","DOIUrl":"10.1002/lary.70374","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate whether preoperative sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with postoperative complications in adults with type 2 diabetes mellitus (T2DM) undergoing open surgical tracheostomy (OST).</p><p><strong>Methods: </strong>We performed a retrospective cohort study using a multi-institutional electronic health record network. Adults with T2DM who underwent OST between 2013 and 2024 were identified using CPT and ICD-10-PCS codes. Exposure was defined as an SGLT2i prescription within 180 days before surgery. One-to-one propensity score matching on demographics, comorbidities, preoperative ventilator dependence, medications, and laboratory values generated balanced SGLT2i and non-SGLT2i cohorts. Ninety- and 180-day postoperative complications were compared using odds ratios (ORs) with 95% confidence intervals, with Benjamini-Hochberg false discovery rate (FDR) correction.</p><p><strong>Results: </strong>Of 36,840 eligible adults (1329 SGLT2i; 35,511 non-SGLT2i), 1327 patients remained in each cohort after matching. At 90 days, SGLT2i use was associated with higher odds of heart failure exacerbation (OR 1.70, 95% CI 1.36-2.14), which remained significant after FDR adjustment. At 180 days, SGLT2i use was associated with increased odds of hypoglycemia (OR 2.01, 95% CI 1.30-3.13) and heart failure exacerbation (OR 1.61, 95% CI 1.30-1.99), both significant after FDR correction. Signals for surgical site infection, tracheostomy stoma malfunction, and dizziness/vertigo did not remain significant after adjustment.</p><p><strong>Conclusion: </strong>In adults with T2DM undergoing OST, preoperative SGLT2i use was associated with increased postoperative hypoglycemia and heart failure exacerbation. These findings support careful perioperative management of SGLT2is in high-risk airway surgery and justify prospective studies to define optimal discontinuation strategies.</p><p><strong>Level of evidence: </strong>3</p>","PeriodicalId":49921,"journal":{"name":"Laryngoscope","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145999555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Simon R Best, Aaron D Friedman, Clark A Rosen, Robert T Sataloff, Laura A Matrka, H Steven Sims, David E Rosow, Nabil F Saba, David G Lott, Adam M Klein, Ted Mau, Milan R Amin, Kathryn A Wikenheiser-Brokamp, Scott M Norberg, Kim McClellan, Geoffrey D Young, Clint T Allen
Objective: With regulatory approval of HPV-specific immunotherapy for recurrent respiratory papillomatosis (RRP) and growing experience with systemic bevacizumab, a management algorithm incorporating these medical treatments is warranted.
Data sources and methods: RRP Foundation (RRPF) Key Opinion Leaders offer a proposed management algorithm for adults with RRP considering published literature and commercial drug availability.
Results: Preventative HPV vaccination should be considered for all patients. Determination of HPV type and pulmonary imaging are important for contemporary RRP patient care and assist in decision making. Risks and benefits of papilloma debulking as needed versus medical management of RRP must be deliberated on a patient case-by-case basis. HPV-specific immunotherapy that induces an HPV-specific T cell response to target the underlying HPV infection that is the cause of RRP is safe, offers the possibility of durable disease control following a short treatment course and is the recommended first-line medical treatment for patients who wish to avoid the risks of repeat procedural management. Papilloma disease control with systemic bevacizumab, which carries defined risks and must be continued for clinical benefit is the recommended second-line medical treatment for patients who do not achieve a complete response with immunotherapy and wish to continue medical management. For patients who elect to be treated with debulking procedures as needed, use of locally-administered adjuvant should be considered.
Conclusion: This proposed management algorithm from the RRPF serves as a contemporary resource and information guide for adult patients with RRP and their physicians considering treatment options.
{"title":"Recurrent Respiratory Papillomatosis Foundation Position Statement on the Management of Adults With RRP.","authors":"Simon R Best, Aaron D Friedman, Clark A Rosen, Robert T Sataloff, Laura A Matrka, H Steven Sims, David E Rosow, Nabil F Saba, David G Lott, Adam M Klein, Ted Mau, Milan R Amin, Kathryn A Wikenheiser-Brokamp, Scott M Norberg, Kim McClellan, Geoffrey D Young, Clint T Allen","doi":"10.1002/lary.70379","DOIUrl":"10.1002/lary.70379","url":null,"abstract":"<p><strong>Objective: </strong>With regulatory approval of HPV-specific immunotherapy for recurrent respiratory papillomatosis (RRP) and growing experience with systemic bevacizumab, a management algorithm incorporating these medical treatments is warranted.</p><p><strong>Data sources and methods: </strong>RRP Foundation (RRPF) Key Opinion Leaders offer a proposed management algorithm for adults with RRP considering published literature and commercial drug availability.</p><p><strong>Results: </strong>Preventative HPV vaccination should be considered for all patients. Determination of HPV type and pulmonary imaging are important for contemporary RRP patient care and assist in decision making. Risks and benefits of papilloma debulking as needed versus medical management of RRP must be deliberated on a patient case-by-case basis. HPV-specific immunotherapy that induces an HPV-specific T cell response to target the underlying HPV infection that is the cause of RRP is safe, offers the possibility of durable disease control following a short treatment course and is the recommended first-line medical treatment for patients who wish to avoid the risks of repeat procedural management. Papilloma disease control with systemic bevacizumab, which carries defined risks and must be continued for clinical benefit is the recommended second-line medical treatment for patients who do not achieve a complete response with immunotherapy and wish to continue medical management. For patients who elect to be treated with debulking procedures as needed, use of locally-administered adjuvant should be considered.</p><p><strong>Conclusion: </strong>This proposed management algorithm from the RRPF serves as a contemporary resource and information guide for adult patients with RRP and their physicians considering treatment options.</p><p><strong>Level of evidence: 5: </strong></p>","PeriodicalId":49921,"journal":{"name":"Laryngoscope","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145991753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rebecca Paquin, Jenny Zablah, Marta Kulich, Jacob Boyd, Max B Mitchell, Gareth Morgan, Jeremy Prager
Objective: To describe the role of optical coherence tomography (OCT) in the evaluation and surgical planning of pediatric patients with complex airway pathology.
Methods: We conducted a retrospective case series of four pediatric patients who underwent OCT imaging of the trachea and mainstem bronchi between 2020 and 2024 at a tertiary children's hospital. Imaging was performed intraoperatively using a microcatheter-based OCT catheter under general anesthesia. OCT findings were reviewed in conjunction with bronchoscopy, preoperative imaging, and operative reports.
Results: In each case, OCT provided high-resolution structural detail that refined diagnosis and informed surgical planning. OCT was instrumental in delineating the extent of stenosis, evaluating mainstem bronchial involvement, and assessing stent patency and epithelialization. OCT imaging demonstrated value both in preoperative assessment and postoperative follow-up.
Conclusion: OCT offers a high-resolution, radiation-free imaging modality for pediatric airway evaluation. In this small, uncontrolled series, OCT served as a feasible adjunct that provided additional structural detail concordant with operative findings and, in selected cases, informed surgical approach. Prospective studies are needed to define workflow, performance, and impact on outcomes.
{"title":"Optical Coherence Tomography in Pediatric Airway Surgery: A Case Series and Focused Review.","authors":"Rebecca Paquin, Jenny Zablah, Marta Kulich, Jacob Boyd, Max B Mitchell, Gareth Morgan, Jeremy Prager","doi":"10.1002/lary.70367","DOIUrl":"https://doi.org/10.1002/lary.70367","url":null,"abstract":"<p><strong>Objective: </strong>To describe the role of optical coherence tomography (OCT) in the evaluation and surgical planning of pediatric patients with complex airway pathology.</p><p><strong>Methods: </strong>We conducted a retrospective case series of four pediatric patients who underwent OCT imaging of the trachea and mainstem bronchi between 2020 and 2024 at a tertiary children's hospital. Imaging was performed intraoperatively using a microcatheter-based OCT catheter under general anesthesia. OCT findings were reviewed in conjunction with bronchoscopy, preoperative imaging, and operative reports.</p><p><strong>Results: </strong>In each case, OCT provided high-resolution structural detail that refined diagnosis and informed surgical planning. OCT was instrumental in delineating the extent of stenosis, evaluating mainstem bronchial involvement, and assessing stent patency and epithelialization. OCT imaging demonstrated value both in preoperative assessment and postoperative follow-up.</p><p><strong>Conclusion: </strong>OCT offers a high-resolution, radiation-free imaging modality for pediatric airway evaluation. In this small, uncontrolled series, OCT served as a feasible adjunct that provided additional structural detail concordant with operative findings and, in selected cases, informed surgical approach. Prospective studies are needed to define workflow, performance, and impact on outcomes.</p><p><strong>Level of evidence: 4: </strong></p>","PeriodicalId":49921,"journal":{"name":"Laryngoscope","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}